Citation Impact
Citing Papers
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Randomized Trial of Sertraline Versus Venlafaxine XR in Major Depression
2005
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Comparative Risk for Harms of Second-Generation Antidepressants
2008
Atypical Depression: Useful Concept, but it's Time to Revise the DSM-IV Criteria
2009
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
Antidepressant Drug Effects and Depression Severity
2010 Standout
Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents
2007
Mirtazapine Orally Disintegrating Tablets Versus Venlafaxine Extended Release
2006
Does Study Design Influence Outcome?
2009
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
2018 Standout
Depression
2018 Standout
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
2006 Standout
Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial
2005
Symptom Severity and Exclusion From Antidepressant Efficacy Trials
2002
Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials
2006
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Borderline Personality Disorder
2008
The neural basis of drug craving: An incentive-sensitization theory of addiction
1993 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
2001
Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication
2005 Standout
DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS
2002
Does low self-esteem predict depression and anxiety? A meta-analysis of longitudinal studies.
2012 Standout
Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons
2000 StandoutNobel
Descending control of pain
2002 Standout
Mechanisms of action of atypical antipsychotic drugs
1991
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
The empirical status of cognitive-behavioral therapy: A review of meta-analyses
2005 Standout
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
2006 Standout
The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide
1988 StandoutNobel
Venlafaxine versus Mirtazapine in the??Treatment of Undifferentiated Somatoform Disorder
2008
Relations between social skills and ward behavior in chronic schizophrenia
1995
Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs
2007
The pharmacology of putative early-onset antidepressant strategies
2003
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Exclusion Criteria Used in Antidepressant Efficacy Trials
2004
Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials
2011
The Structure of Common Mental Disorders
1999
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
2017
The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis
2010 Standout
Measuring inconsistency in meta-analyses
2003 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Quality of life assessments in major depressive disorder: a review of the literature
2004
St John's Wort for depression
1998
Mental Illness and/or Mental Health? Investigating Axioms of the Complete State Model of Health.
2005 Standout
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Hubris syndrome: An acquired personality disorder? A study of US Presidents and UK Prime Ministers over the last 100 years
2009 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
The SSRI antidepressants: Exploring their “other” possible properties
1998
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Iron catalysed direct alkylation of amines with alcohols
2014 StandoutNobel
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
2010 Standout
Dopamine receptors and brain function
1996
Safety Reporting and Adverse-Event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-Phase Treatment of Adults with Depression
2009
How does sexual minority stigma “get under the skin”? A psychological mediation framework.
2009 Standout
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs
2000
Mirtazapine Versus Venlafaxine in Hospitalized Severely Depressed Patients With Melancholic Features
2001
"Wish Bias" in Antidepressant Drug Trials?
2004
Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis
1995
Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study
2004
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: A meta-analysis
2002
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
1996
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians
2008
Fluoxetine versus other types of pharmacotherapy for depression
2013
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
2002
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Efficacy and Safety of Second-Generation Antidepressants in the Treatment of Major Depressive Disorder
2005
Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs)
2006
Towards More Effective Antipsychotic Treatment
1994
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression
2000
Effects of neuroleptic drugs, clonidine and lithium on the expression of conditioned behavioral excitation in rats
1987
Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs
2010
Citalopram versus other anti-depressive agents for depression
2012
Paroxetine versus other anti-depressive agents for depression
2014
The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
2011 Standout
Treatment and Prevention of Depression
2002
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
1999 Standout
Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health
2003
Temporomandibular Disorders
2008 Standout
Rethinking Rumination
2008 Standout
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2
2000 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Development of a new resilience scale: The Connor-Davidson Resilience Scale (CD-RISC)
2003 Standout
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study
2007
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Dopamine Receptors: From Structure to Function
1998 Standout
Industry sponsorship and research outcome
2017 Standout
Works of K. Behnke being referenced
Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double‐blind, randomised 6‐month comparative trial with citalopram
2004
The Brief Psychiatric Rating Scale
1989
Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression
2002
Paroxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study
1995
Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder
1999
Mirtazapine Orally Disintegrating Tablet Versus Sertraline: A Prospective Onset of Action Study
2003
A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder
1993
Paroxetine and amitriptyline in the treatment of depression in general practice
1996
Randomized, Double-Blind Comparison of Venlafaxine and Sertraline in Outpatients With Major Depressive Disorder
2000
A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients With Bipolar I Disorder
2003
Sulpiride and Haloperidol in Schizophrenia: A Double-blind Cross-over Study of Therapeutic Effect, Side Effects and Plasma Concentrations
1985
A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression
1999
Sulpiride versus Haloperidol, a Clinical Trial in Schizophrenia. A preliminary report
1984
Mirtazapine has similar long-term efficacy and tolerability to citalopram and faster onset of action in the treatment of major depression
2000
Paroxetine in the treatment of panic disorder
1993